Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 15.40
-0.36 (-2.28%)
Jun 6, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 42.88 billion as of June 6, 2025. Its market cap has increased by 16.81% in one year.
Market Cap
42.88B
Enterprise Value
47.11B
Revenue
13.62B
Ranking
n/a
PE Ratio
21.41
Stock Price
15.40
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 42.88B, an increase of 409.23%. That is a compound annual growth rate of 29.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 240.35B |
| Hansoh Pharmaceutical Group Company | 157.27B |
| JD Health International | 126.08B |
| Innovent Biologics | 119.26B |
| WuXi Biologics | 101.31B |
| CSPC Pharmaceutical Group | 89.83B |
| Sino Biopharmaceutical | 81.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.74B |